LEADER 03261nam 22010093a 450 001 9910367751903321 005 20250203235437.0 010 $a9783039216772 010 $a3039216775 024 8 $a10.3390/books978-3-03921-677-2 035 $a(CKB)4100000010106198 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54599 035 $a(ScCtBLL)11dc1b6a-e5e4-457d-b656-26a0e89e0cfb 035 $a(OCoLC)1163804709 035 $a(EXLCZ)994100000010106198 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNew Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases : $eLessons From The Past and Future Challenges /$fAhmed Bakillah 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (116 p.) 311 08$a9783039216765 311 08$a3039216767 330 $aThis book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies. 610 $aapolipoprotein 610 $alipids 610 $arisk stratification 610 $aproprotein convertase subtilisin-kexin type 9 (PCSK9) 610 $avaspin 610 $asphingolipids 610 $aPCSK9 610 $aceramides 610 $aatrial fibrillation 610 $acircular RNA 610 $aSTEMI 610 $acholesterol 610 $alipoproteins 610 $acardiovascular disease (CVD) 610 $acoronary artery bypass grafting 610 $aatherosclerosis 610 $astatin 610 $aLDL subfractions 610 $aacute kidney injury 610 $adyslipidemia 610 $agene expression 610 $aNSTEMI 610 $aNAFLD 610 $ahyperlipidemia 610 $anonstatin 610 $acholesteryl ester transfer protein 610 $alow-density lipoprotein cholesterol 610 $aanacetrapib 610 $aHDL 610 $aacute coronary syndrome 610 $amiRNA 610 $acardiovascular risk 610 $apleiotropic actions 610 $agenetic 610 $aABCA1 610 $asdLDL 610 $acardiovascular disease 610 $aproprotein convertase subtilisin/kexin type 9 610 $ainclisiran 610 $areverse cholesterol transport 610 $asterol 610 $asmall interfering RNA (siRNA) 610 $aRNA-binding proteins 610 $acardiovascular diseases 610 $aNASH 610 $alow-density lipoprotein-cholesterol (LDL-C) 610 $astroke 610 $anutrigenetics 610 $atype 2 diabetes 610 $astatins 610 $asphingomyelin 610 $ahepatic fibrosis 610 $adiabetes 700 $aBakillah$b Ahmed$01287692 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910367751903321 996 $aNew Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases$94322787 997 $aUNINA